Dongfang Baitai was selected as a backup enterprise of "G20 Project" in Beijing's biomedical industry
- Categories:Company News
- Author:
- Origin:Dongfang Baitai
- Time of issue:2022-05-20
- Views:613
(Summary description)In September 2016, the Beijing Municipal Science and Technology Commission released the list of the first batch of G20 enterprises and G20 backup enterprises during the "13th Five Year Plan" period. Beijing Dongfang Baitai Biotechnology Co., Ltd. was successfully selected as a G20 backup enterprise.
Dongfang Baitai was selected as a backup enterprise of "G20 Project" in Beijing's biomedical industry
(Summary description)In September 2016, the Beijing Municipal Science and Technology Commission released the list of the first batch of G20 enterprises and G20 backup enterprises during the "13th Five Year Plan" period. Beijing Dongfang Baitai Biotechnology Co., Ltd. was successfully selected as a G20 backup enterprise.
- Categories:Company News
- Author:
- Origin:Dongfang Baitai
- Time of issue:2022-05-20
- Views:613
In September 2016, the Beijing Municipal Science and Technology Commission released the list of the first batch of G20 enterprises and G20 backup enterprises during the "13th Five Year Plan" period. Beijing Dongfang Baitai Biotechnology Co., Ltd. was successfully selected as a G20 backup enterprise.
What is the "G20 Project"
In 2009, the Beijing Municipal Government issued and implemented the Science and Technology Beijing Action Plan. It regards the biological medicine industry as one of the eight projects of science and technology to revitalize the industry. In 2010, the Municipal Science and Technology Commission, the Municipal Economic Informatization Commission, the Zhongguancun Management Committee, the Municipal Investment Promotion Bureau and other departments started to implement the "leapfrog development project of Beijing's biomedical industry", namely the "G20 project". With the general idea of "government guidance, market selection, enterprise focus and scale development", it has selected and identified a number of G20 enterprises as the key to implement the G20 project and promote industrial development.
"G" is the first letter of "Great" in English, which means a key enterprise with large scale and great contribution. "20" means the most important 20% of the "28" rule. It means that the government will support 20% of key enterprises with 80% of resources. It is intended to promote the development of Beijing's biomedical industry through policy support and resource tilt.
The G20 project plans to expand the overall scale of Beijing's bio pharmaceutical industry to 180 billion yuan in the next three years. It has established the dominant position of Beijing's bio pharmaceutical industry in the country. It realizes the strategic transformation and leapfrog development of Beijing's bio pharmaceutical industry from "small scattered weak" to "high concentrated strong". G20 enterprises will constitute the main body of Beijing's 100 billion yuan industrial scale in the future and the core force of its pillar industries.
Beijing Dongfang Baitai was selected as the backup enterprise of G20 project this time, which is a recognition of our achievements in innovative drug research and development over the years. We will continue to increase investment in research and development, improve the level of scientific research management, and make positive contributions to the development of the capital's pharmaceutical industry.
Scan the QR code to read on your phone
推荐新闻
Follow us

Follow the official WeChat official account
Or search "Oriental Baitai"
More exciting waiting for you!
Address: No. 2, Rongjing East Street, Beijing Economic and Technological Development Zone
Tel.: 010-51571019
Email: ebt@east-bt.com
Copyright 2021 Beijing Dongfang Baitai Biotechnology Co., Ltd SEO 京ICP备********号